Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for Evolus (EOLS) over the last 7 years, with Q3 2025 value amounting to $23.1 million.

  • Evolus' Cost of Revenue rose 2180.55% to $23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.4 million, marking a year-over-year increase of 1939.24%. This contributed to the annual value of $84.0 million for FY2024, which is 3015.78% up from last year.
  • According to the latest figures from Q3 2025, Evolus' Cost of Revenue is $23.1 million, which was up 2180.55% from $24.1 million recorded in Q2 2025.
  • Evolus' 5-year Cost of Revenue high stood at $26.3 million for Q4 2024, and its period low was $4.9 million during Q1 2021.
  • For the 5-year period, Evolus' Cost of Revenue averaged around $16.8 million, with its median value being $15.8 million (2021).
  • In the last 5 years, Evolus' Cost of Revenue skyrocketed by 48018.48% in 2021 and then tumbled by 804.06% in 2023.
  • Over the past 5 years, Evolus' Cost of Revenue (Quarter) stood at $15.8 million in 2021, then increased by 3.1% to $16.3 million in 2022, then soared by 36.14% to $22.2 million in 2023, then grew by 18.39% to $26.3 million in 2024, then decreased by 12.11% to $23.1 million in 2025.
  • Its Cost of Revenue stands at $23.1 million for Q3 2025, versus $24.1 million for Q2 2025 and $21.9 million for Q1 2025.